Prunus yedoensis Bark Downregulates the Expression of Cell Adhesion Molecules in Human Endothelial Cell Lines and Relaxes Blood Vessels in Rat Aortic Rings.
Ye Eun ChoiJung Mo YangChae Won JeongSujin ShinJunkyu ParkKyungjin LeeJu Hyun ChoPublished in: Pharmaceuticals (Basel, Switzerland) (2024)
The incidence of cardiovascular diseases, such as high blood pressure, is increasing worldwide, owing to population aging and irregular lifestyle habits. Previous studies have reported the vasorelaxant effects of Prunus yedoensis bark methanol extract. However, various solvent extracts of P. yedoensis bark and their vascular relaxation mechanisms have not been sufficiently studied. We prepared extracts of P. yedoensis bark using various solvents (water, 30% ethanol, and 70% ethanol). P. yedoensis bark 30% ethanol extract (PYB-30E) decreased the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin in human umbilical vein endothelial cells (HUVECs) activated with 200 ng/mL TNF-α. Additionally, PYB-30E showed vasodilatory effects on isolated rat aortic rings. This was confirmed to be the result of the activation of the NO/cGMP pathway, regulation of non-selective calcium-activated K + channels, and calcium channel blockade. Additionally, PYB-30E significantly reduced systolic and diastolic blood pressure in spontaneously hypertensive rats (SHR). Taken together, our results indicated that PYB-30E is a candidate functional material with preventive and therapeutic effects against hypertension.
Keyphrases
- cell adhesion
- blood pressure
- endothelial cells
- left ventricular
- hypertensive patients
- oxidative stress
- poor prognosis
- cardiovascular disease
- heart rate
- aortic valve
- nitric oxide
- ionic liquid
- rheumatoid arthritis
- physical activity
- high glucose
- risk factors
- anti inflammatory
- blood glucose
- long non coding rna
- staphylococcus aureus
- vascular endothelial growth factor
- carbon dioxide
- escherichia coli
- cystic fibrosis
- atrial fibrillation
- cardiovascular events
- pulmonary arterial hypertension